Position in BDSX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$597,023
New position
Shares Held
41,174
first reported quarter
Ownership
0.407%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#15
of 40 holders
Holding Since
Mar 2026
1 quarter on record
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Legato Capital Management LLC holds $11,076,427 across 7 Diagnostics & Research names. BDSX ranks #6 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MTD |
Mettler Toledo International Inc/
|
2,400 | $3,026,880 | |
| 2 | ILMN |
Illumina, Inc.
|
19,300 | $2,378,918 | |
| 3 | ADPT |
Adaptive Biotechnologies Corp
|
152,339 | $2,114,465 | |
| 4 | GRAL |
GRAIL, Inc.
|
39,400 | $2,036,192 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
1,300 | $624,247 | |
| 6 | BDSX |
Biodesix Inc
This page
|
41,174 | $597,023 | |
| 7 | SHC |
Sotera Health Co
|
20,830 | $298,702 |
All Filings in BDSX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $597,023 | 41,174 | Shares | Other | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||